[O-17] Oral Session 17 ［English］「Neuroinfection 1」

[O-17-4] Development of molecular-targeted drug for HTLV-1-associated myelopathy (HAM)

Daisuke Kodama^1,3, Masakazu Tanaka¹, Toshio Matsuzaki^2,3, Satoshi Nozuma³, Eiji Matsuura³, Hiroshi Takashima³, Shuji Izumo¹, Ryuji Kubota¹ (1.Joint Research Center for Human Retrovirus Infection, Kagoshima University, Division of Neuroimmunology, Japan, 2.Medical Corporation Sanshukai Ohkatsu Hospital, Department of neurology, Japan, 3.Kagoshima University Graduate School of Medical and Dental Sciences, Department of Neurology and Geriatrics, Japan)